Current report according to ASF Regulation no. 5/2018
Report date: | 26.08.2026 |
Name of issuer: | Farmaceutica REMEDIA SA |
Registered office: | Deva, no. 2, Nicolae Bălcescu Blvd |
Tel/ fax no: | +40 254 22 32 60 / +40 254 22 61 97 |
ORC no: | 2115198 |
Trade Registry no: | J1991000700203 |
Subscribed and paid-in capital: | LEI 9.548.082 |
Regulated market: | Bucharest Stock Exchange, Standard Category |
RELEASE
The Board of Administrators of Farmaceutica REMEDIA SA informs that the Report for the 1st Semester of 2026 - the full version - is available on its own website https://corporate.remedia.ro/en/investor-relationship/financial-information/ and in the link from the IRIS platform, below.
During 01.01.2026 - 30.06.2026, Farmaceutica REMEDIA SA recorded the following consolidated financial results:
Crt. | Indicator | Realisations | Realisations | Evolution |
No. | Jan-June 2026 (Lei) | Jan-June 2025 (Lei)** | 2026/2025 (%) | |
1. | Net sales of goods * | 341.980.070 | 362.434.169 | -5,64% |
2. | Other operating revenues | 3.965.585 | 5.647.594 | -29,78% |
3. | Total operating income | 345.945.655 | 368.081.762 | -6,01% |
4. | Total operational costs * | 344.167.695 | 359.914.258 | -4,38% |
5. | Operating result | 1.777.960 | 8.167.504 | -78,23% |
6. | Financial result | 1.037.499 | 674.396 | 53,84% |
7. | Gross result | 2.815.459 | 8.841.900 | -68,16% |
* Including trade discounts granted/received
The economic - financial indicators on 30.06.2026 are presented in the following table:
LIQUIDITY AND WORKING CAPITAL | Farmaceutica REMEDIA SA | Farmaceutica REMEDIA Distribution & Logistics SRL |
Current liquidity (Current assets / Current debts) | 3,07 | 1,05 |
Current assets | 20.737.378 | 273.319.154 |
Current debts | 6.753.456 | 260.896.206 |
Degree of indebtedness (Borrowed capital / Equity x 100) | 0 | 0% |
Borrowed capital | 0 | 0 |
Equity | 56.207.959 | 18.652.922 |
Turnover speed for client debit items (Average customer balance /turnover *180) | 141 days | 99 days |
Average customer balance | 2.754.543 | 190.126.316 |
Net turnover | 3.527.879 | 343.968.762 |
Turnover speed of stocks (average stock/ net COGS)*180 | 486 days | 32 days |
Average stock | 967.199 | 56.672.529 |
COGS net | 358.273 | 316.205.786 |
*including financial leasing
Notes:- Current liquidity - the indicator level reflects a good payment capacity, therefore a reduced risk for creditors in case of FR and FRDL, certifying that the companies are able to cover their short-term debts based on receivables and cash availabilities.
- Degree of indebtedness expresses the effectiveness of credit risk management, indicating potential financing, liquidity problems, with influences in honouring the assumed commitments. In the case of FR and FRDL there is no risk at all. In the calculation of this indicator, the borrowed capital comprises both bank credits, and financial leasing debts.
- Turnover speed for client debit items expresses company effectiveness in collecting its receivables, respectively the number of days until the date on which debtors pay their debts to the company. Considering the dynamics of sales and the specifics of receivables in the distribution of medicines, we consider that the value of the indicator is normal for the companies from the group, under the given conditions.
The value of the indicator No. of days of storage can be regarded as falling within the scope of the business's specific operations, being influenced, in the case of FR, by the high level of stock represented by the BD Rowa robot. This is purchased exclusively on the basis of a firm order and an accepted quotation.
Chairman of the Board of Administrators,
"TARUS" - Valentin Norbert TARUS e.U.